常見問題
Q&A
-
我需要接受多少次Belkyra®溶脂療程？ How many Belkyra® treatments will I need?
每個人的雙下巴狀況都不同，因此所需的療程次數及劑量亦有所不同。根據臨床研究顯示，大部分用家需接受 2 – 4 次療程來達致理想效果。最多可進行6次療程。8,9 Since everyone’s chin profile is different, the number of treatments varies from one to another. According to clinic studies, most users undergo 2 – 4 treatment sessions to achieve expected results, and a maximum of 6 treatments can be performed.8,9 -
療效能維持多久？ How long will results last?
Belkyra®溶脂療程針對分解脂肪細胞，而已被破壞的細胞不能再儲存或累積脂肪，達致不可逆轉的溶脂效果。達致預期目標效果後，無需再重覆療程，效果永久不反彈。4,6 Belkyra® causes the destruction of fat cells under chin. Once destroyed, those cells cannot store or accumulate fat. After final aesthetics result achieved, a durable effect is expected.4,6 -
療程後，我會有甚麼改變？ What should I notice after treatment?
療程後出現腫脹、發麻是藥效發揮的必經過程。大部分的療程後反應可在30 天內逐漸改善。13 After treatment, you may experience swelling, pain, or numbness under your chin. Most condition will resolve gradually within 30 days.13
*Minimal invasive treatment in adipolysis †Approved as Kybella™ in US10
^資料來源：根據美國食物及藥物監督管理局 (U.S. Food and Drug Administration) 官方網站, 去氧膽酸(Belkyra®主要成份) 是認可用作改善雙下巴脂肪8
https://www.fda.gov/search?s=deoxycholic+acid (截至2022年8月9日).
References: 1. Goodman GJ, et al. Dermatol Surg 2016;42(suppl 1):S260-262. 2. DeFatta R, Ducic Y.
Oper Tech Otolaryngol 2007;18(3):261-266. 3. Ascher B, et al. J Eur Acad Dermatol Venereol 2014
Dec;28(12):1707-15. 4. Humphrey S, et al. J Am Acad Dermatol 2016;75(4):788-797; 5. Jones DH, et al.
Dermatol Surg 2016;42(1):38-49; 6. Rzany B, et al. Br J Dermatol. 2014;170(2):445-453; 7.
Schlessinger J, et al. Skinmed. 2013;11:27–31; 8. Dayan SH, et al. Dermatol Surg 2016;42(suppl
1):S263–S270; 9. Belkyra® Prescribing Information. March 2021; 10. U.S. Food and Drug
Administration, Department of Health & Human Services. Kyrbella™ deoxycholic acid injection, 10mg/ml
approval letter NDA 206333, Apr 2015; 11. European Medicines Agency. List of nationally authorized
medicinal products. EMA/753957/2017. November 2017; 12. Bhatia AC, et al. Poster presented at The
Maui Derm for Dermatologists Conference. 20-24 March 2017; 13. Teller CF et al. Plast Reconstr Surg
Glob Open. 2021 Jul 12;9(7):e3668; 14. Photo courtesy: Dr Vincent Yang.
Belkyra® (deoxycholic acid) 藥品註冊編號:
HK-65660。Belkyra®為醫生處方藥物，請向醫生或醫學美容中心諮詢切合您獨特需要的專屬療程方案。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢。All adverse events
should be reported to drugsafety.pv@abbvie.com.
香港北角電氣道 183 號友邦廣場 24 樓 2404-08 室電話: (852)26102525
© 2022 Allergan Aesthetics. All right reserved. Approval Date: HK-BEL-240005 | 19/JUL/24
